Ocuphire Pharma Inc (OCUP) USD0.0001
Sell:$1.65Buy:$1.87
$0.07 (4.02%)
- This stock can be held in a
Stocks and Shares ISASell:$1.65
Buy:$1.87
Change:$0.07 (4.02%)
$0.07 (4.02%)Prices delayed by at least 15 minutes
Sell:$1.65
Buy:$1.87
Change:$0.07 (4.02%)
$0.07 (4.02%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 21 March 2024 | Nirav S JhaveriCFO | Buy Regular purchase transaction | 10,000 | $2.10 | $21,000.00 | 150,000 |
| 21 March 2024 | Joseph K (Joe) SchachleCOO | Buy Regular purchase transaction | 2,000 | $2.05 | $4,100.00 | 2,000 |
| 18 March 2024 | George MagrathCEO | Buy Regular purchase transaction | 25,000 | $1.96 | $49,050.00 | 425,000 |
| 10 January 2024 | Bernhard (Charlie) HoffmannSenior Vice President | Sell Tax related | 4,031 | $3.27 | $13,161.22 | 142,697 |
| 10 January 2024 | Ronil A PatelVice President | Sell Tax related | 1,282 | $3.27 | $4,185.73 | 90,714 |
| 10 January 2024 | Rabourn Amy ZarembaVice President | Sell Tax related | 3,950 | $3.27 | $12,896.75 | 42,658 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 18 March 2024 | George MagrathCEO | Buy Regular purchase transaction | 25,000 | $1.96 | $49,050.00 | 425,000 |
| 21 March 2024 | Nirav S JhaveriCFO | Buy Regular purchase transaction | 10,000 | $2.10 | $21,000.00 | 150,000 |
| 10 January 2024 | Bernhard (Charlie) HoffmannSenior Vice President | Sell Tax related | 4,031 | $3.27 | $13,161.22 | 142,697 |
| 10 January 2024 | Rabourn Amy ZarembaVice President | Sell Tax related | 3,950 | $3.27 | $12,896.75 | 42,658 |
| 10 January 2024 | Ronil A PatelVice President | Sell Tax related | 1,282 | $3.27 | $4,185.73 | 90,714 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.